SCHEMBL24691256

SCHEMBL24691256

O=CNCC(=O)NC(CC1CCNC1=O)C(=O)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25573410 0.89 CTSL (0.42) —
SCHEMBL24710027 0.84 CTSV (0.49) —
SCHEMBL25134289 0.83 CTSL (0.36) —
SCHEMBL23824512 0.81 CTSV (0.36) —
SCHEMBL6515959 0.81 CTSV (0.36) —
SCHEMBL23824515 0.81 CTSV (0.36) —
SCHEMBL23506239 0.81 — —
SCHEMBL24766273 0.81 — —
SCHEMBL23506543 0.81 — —
SCHEMBL23722272 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256434-A1 PROTEASE INHIBITORS AS ANTIVIRALS ACEA Therapeutics, Inc. (US) 2022-12-08 — — WO disclosed
Send feedback